CymitQuimica logo

CAS 1788-93-8

:

3-(4-Chlorophenyl)-2-methyl-4(3H)-quinazolinone

Description:
3-(4-Chlorophenyl)-2-methyl-4(3H)-quinazolinone, with the CAS number 1788-93-8, is a synthetic organic compound belonging to the quinazolinone class. This compound features a quinazolinone core, which is characterized by a fused bicyclic structure containing a benzene ring and a pyrimidine ring. The presence of a 4-chlorophenyl group at the 3-position and a methyl group at the 2-position contributes to its unique chemical properties and potential biological activity. Quinazolinones are known for their diverse pharmacological activities, including anti-inflammatory, analgesic, and anticancer properties. The chlorine substituent can influence the compound's lipophilicity and biological interactions, potentially enhancing its efficacy in various applications. Additionally, the compound's structure allows for various synthetic modifications, making it a valuable scaffold in medicinal chemistry. Its solubility, stability, and reactivity can vary based on environmental conditions and the presence of other functional groups, which are important considerations in its application in research and development.
Formula:C15H11ClN2O
InChI:InChI=1S/C15H11ClN2O/c1-10-17-14-5-3-2-4-13(14)15(19)18(10)12-8-6-11(16)7-9-12/h2-9H,1H3
InChI key:InChIKey=CDVPWZBQQSFPFX-UHFFFAOYSA-N
SMILES:O=C1N(C(C)=NC=2C1=CC=CC2)C3=CC=C(Cl)C=C3
Synonyms:
  • 2-Methyl-3-(p-chlorophenyl)-4-quinazolone
  • 3-(4-Chlorophenyl)-2-methyl-4(3H)-quinazolinone
  • 4(3H)-Quinazolinone, 3-(4-chlorophenyl)-2-methyl-
  • 4(3H)-Quinazolinone, 3-(p-chlorophenyl)-2-methyl-
  • Menilon
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 1 products.
  • 3-(4-Chlorophenyl)-2-methyl-3,4-dihydroquinazolin-4-one
    Biosynth
    + Info

    3-(4-Chlorophenyl)-2-methyl-3,4-dihydroquinazolin-4-one

    Controlled Product
    CAS:
    <p>3-(4-Chlorophenyl)-2-methyl-3,4-dihydroquinazolin-4-one (CLQ) is a compound that has been shown to have a hypothermic effect in animals. CLQ also has pharmacological properties and has been used in experiments to study the correlation between maximal concentration and hypothermic effects. The drug was found to be active when administered at a dose of 0.5 mg/kg body weight. CLQ has not been tested for its effects on seizures or epilepsy, but it is thought that it may have antiseizure activity due to its inhibition of nitric oxide synthase.</p>
    Formula:C15H11ClN2O
    Purity:Min. 95%
    Molecular weight:270.71 g/mol

    Ref: 3D-BAA78893

    5g
    1,681.00€
    500mg
    486.00€